gamma biosciences holdco limited
gamma biosciences holdco limited Company Information
Company Number
12558722
Next Accounts
95 days late
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Shareholders
gamma biosciences bidco limited
Group Structure
View All
Contact
Registered Address
duo, level 6 280 bishopsgate, london, EC2M 4RB
Website
-gamma biosciences holdco limited Estimated Valuation
Pomanda estimates the enterprise value of GAMMA BIOSCIENCES HOLDCO LIMITED at £0 based on a Turnover of £-18.4m and 0.57x industry multiple (adjusted for size and gross margin).
gamma biosciences holdco limited Estimated Valuation
Pomanda estimates the enterprise value of GAMMA BIOSCIENCES HOLDCO LIMITED at £0 based on an EBITDA of £-18.5m and a 2.45x industry multiple (adjusted for size and gross margin).
gamma biosciences holdco limited Estimated Valuation
Pomanda estimates the enterprise value of GAMMA BIOSCIENCES HOLDCO LIMITED at £10.4m based on Net Assets of £8.2m and 1.26x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Gamma Biosciences Holdco Limited Overview
Gamma Biosciences Holdco Limited is a live company located in london, EC2M 4RB with a Companies House number of 12558722. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in April 2020, it's largest shareholder is gamma biosciences bidco limited with a 100% stake. Gamma Biosciences Holdco Limited is a startup, micro sized company, Pomanda has estimated its turnover at £-18.4m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Gamma Biosciences Holdco Limited Health Check
Pomanda's financial health check has awarded Gamma Biosciences Holdco Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 2 areas for improvement. Company Health Check FAQs
1 Strong
4 Regular
2 Weak
Size
annual sales of £-18.4m, make it smaller than the average company (£18m)
£-18.4m - Gamma Biosciences Holdco Limited
£18m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Gamma Biosciences Holdco Limited
- - Industry AVG
Production
with a gross margin of 36.2%, this company has a comparable cost of product (36.2%)
36.2% - Gamma Biosciences Holdco Limited
36.2% - Industry AVG
Profitability
an operating margin of 100.1% make it more profitable than the average company (5.3%)
100.1% - Gamma Biosciences Holdco Limited
5.3% - Industry AVG
Employees
with -102 employees, this is below the industry average (104)
- Gamma Biosciences Holdco Limited
104 - Industry AVG
Pay Structure
on an average salary of £41.9k, the company has an equivalent pay structure (£41.9k)
- Gamma Biosciences Holdco Limited
£41.9k - Industry AVG
Efficiency
resulting in sales per employee of £180.7k, this is equally as efficient (£178.4k)
- Gamma Biosciences Holdco Limited
£178.4k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Gamma Biosciences Holdco Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Gamma Biosciences Holdco Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Gamma Biosciences Holdco Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Gamma Biosciences Holdco Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 76.3%, this is a similar level of debt than the average (69.7%)
76.3% - Gamma Biosciences Holdco Limited
69.7% - Industry AVG
GAMMA BIOSCIENCES HOLDCO LIMITED financials
Gamma Biosciences Holdco Limited's latest turnover from December 2022 is -£18.4 million and the company has net assets of £8.2 million. According to their latest financial statements, we estimate that Gamma Biosciences Holdco Limited has no employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Turnover | -18,428,722 | -8,228,459 | -28,534,962 |
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 |
| Pre-Tax Profit | -18,454,273 | -8,408,792 | -28,540,261 |
| Tax | 0 | 0 | 0 |
| Profit After Tax | -18,454,273 | -8,408,792 | -28,540,261 |
| Dividends Paid | 0 | 0 | 0 |
| Retained Profit | -18,454,273 | -8,408,792 | -28,540,261 |
| Employee Costs | |||
| Number Of Employees | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Investments & Other | 32,772,891 | 26,690,757 | 25,133,492 |
| Debtors (Due After 1 year) | 0 | 0 | 0 |
| Total Fixed Assets | 32,772,891 | 26,690,757 | 25,133,492 |
| Stock & work in progress | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 |
| Group Debtors | 1,990,790 | 8,154 | 1,152,811 |
| Misc Debtors | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 |
| total current assets | 1,990,790 | 8,155 | 1,152,811 |
| total assets | 34,763,681 | 26,698,911 | 26,286,304 |
| Bank overdraft | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 |
| Group/Directors Accounts | 26,515,664 | 0 | 3,761 |
| other short term finances | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| other current liabilities | 11,533 | 8,155 | 0 |
| total current liabilities | 26,527,197 | 8,155 | 3,761 |
| loans | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 |
| total liabilities | 26,527,197 | 8,155 | 3,761 |
| net assets | 8,236,483 | 26,690,756 | 26,282,542 |
| total shareholders funds | 8,236,483 | 26,690,756 | 26,282,542 |
| Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 |
| Debtors | 1,982,636 | -1,144,657 | 1,152,811 |
| Creditors | 0 | 0 | 0 |
| Accruals and Deferred Income | 3,378 | 8,155 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 |
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | 6,082,134 | 1,557,264 | 25,133,492 |
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | 0 | 0 | 0 |
| Group/Directors Accounts | 26,515,664 | -3,761 | 3,761 |
| Other Short Term Loans | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 |
| share issue | |||
| interest | 0 | 0 | 0 |
| cash flow from financing | 26,515,664 | 8,813,245 | 54,826,564 |
| cash and cash equivalents | |||
| cash | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 |
gamma biosciences holdco limited Credit Report and Business Information
Gamma Biosciences Holdco Limited Competitor Analysis
Perform a competitor analysis for gamma biosciences holdco limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other micro companies, companies in EC2M area or any other competitors across 12 key performance metrics.
gamma biosciences holdco limited Ownership
GAMMA BIOSCIENCES HOLDCO LIMITED group structure
Gamma Biosciences Holdco Limited has 2 subsidiary companies.
Ultimate parent company
GAMMA BIOSCIENCES LP
#0119795
2 parents
GAMMA BIOSCIENCES HOLDCO LIMITED
12558722
2 subsidiaries
gamma biosciences holdco limited directors
Gamma Biosciences Holdco Limited currently has 2 directors. The longest serving directors include Mr Matthew Gunnison (Apr 2020) and Mr Eric Simpson (Jun 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Matthew Gunnison | England | 45 years | Apr 2020 | - | Director |
| Mr Eric Simpson | United Kingdom | 38 years | Jun 2023 | - | Director |
P&L
December 2022turnover
-18.4m
+124%
operating profit
-18.5m
0%
gross margin
36.3%
+3.34%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
8.2m
-0.69%
total assets
34.8m
+0.3%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
gamma biosciences holdco limited company details
company number
12558722
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
April 2020
age
4
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2022
previous names
N/A
accountant
-
auditor
-
address
duo, level 6 280 bishopsgate, london, EC2M 4RB
Bank
-
Legal Advisor
-
gamma biosciences holdco limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to gamma biosciences holdco limited.
gamma biosciences holdco limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GAMMA BIOSCIENCES HOLDCO LIMITED. This can take several minutes, an email will notify you when this has completed.
gamma biosciences holdco limited Companies House Filings - See Documents
| date | description | view/download |
|---|
